{"id":47799,"date":"2022-08-30T14:02:25","date_gmt":"2022-08-30T12:02:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/"},"modified":"2022-08-30T14:02:25","modified_gmt":"2022-08-30T12:02:25","slug":"healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/","title":{"rendered":"Healee Lands $2M to Grow Customizable Telehealth Solution in the U.S."},"content":{"rendered":"
\n

\nNew funding round led by Nina Capital enables Healee to empower unique digital health models and accelerate telehealth adoption\n<\/p>\n

<\/a><\/p>\n

TAMPA, Fla.–(BUSINESS WIRE)–#custom<\/a>—Healee<\/a>, providing highly configurable digital health technology, announced today that it has raised $2M in a seed round led by Nina Capital, with the participation of Calm\/Storm Ventures, KAYA VC and existing investor Eleven Ventures, to fund U.S. expansion and technology development.\n<\/p>\n

\nSupporting unique use cases in digital health<\/b>\n<\/p>\n

\nHealee\u2019s technology enables healthcare organizations to quickly launch ready infrastructure for telehealth, digital check-in and scheduling, configured to custom workflows and branding. Healee gained market momentum in the U.S. with over a dozen customers in under a year.\n<\/p>\n

\nCurrent applications span from traditional healthcare, insurance and pharma, to niche services in wellness, behavioral health, chronic and palliative care, COVID consultations, and many more.\n<\/p>\n

\nEliminating barriers to telehealth adoption<\/b>\n<\/p>\n

\nAccording to a 2022 report by HIMSS on the state of healthcare, close to 80% of all health systems in the U.S. are still in their planning stages for digital transformation. The barriers include poor tool fit to organizational workflows and lack of proper customization.\n<\/p>\n

\nHealee devised a new \u201cdeep white label<\/a>\u201d solution category to eliminate those barriers. A Healee-based platform replaces a multitude of existing tools to alleviate digital fatigue and fit clinical processes closely.\n<\/p>\n

\n\u201cHealee offers you an advanced, yet easy way to get started with digital health while building your brand and adapting your tool for better user engagement,\u201d said Hristo Kosev, CEO and founder of Healee.<\/b>\n<\/p>\n

\n\u201cHealee is prepared for the next disruption wave in virtual care, now driven by the growing need for hybrid or virtual-first care models. Healee has taken an enabling technology platform approach to becoming a leader in this wave, with the ability to support any distinct virtual care use case,\u201d said Marc Subirats, general partner at Nina Capital<\/b>.\n<\/p>\n

\nFor learning more about Healee\u2019s deep white label approach, read the white paper \u201c7 Surprising Benefits that Deep White Label Brings to Digital Health<\/a>\u201d.\n<\/p>\n

\nAbout Healee<\/b>\n<\/p>\n

\nHealee is a health tech company that helps digital health innovators quickly implement unique virtual care models with advanced technology adaptable to any use case. Healee\u2019s unique platform configurability approach allows creating a fully-branded patient experience and enabling all organizational workflows for telehealth, scheduling and digital check-in.\n<\/p>\n

\nLearn more at https:\/\/www.healee.com\/en<\/a>.\n<\/p>\n

\nAbout Nina Capital<\/b>\n<\/p>\n

\nNina Capital is a specialized venture capital firm that invests exclusively at the intersection of healthcare and technology, with a focus on pre-seed and seed investments and the capacity for follow-on at the Series A. Founded in 2019, Nina Capital manages two fully subscribed funds, a 2019 vintage and a 2021 vintage. To date, the firm has made investments in 34 health tech startups headquartered in 16 different countries, with a team of professionals based in Barcelona, Spain, a growing international network of advisers and venture partners, and a strong base of private investors. Learn more at https:\/\/www.nina.capital<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nVera Iordanova<\/a>
Healee
\n
vera@healee.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

New funding round led by Nina Capital enables Healee to empower unique digital health models and accelerate telehealth adoption TAMPA, Fla.–(BUSINESS WIRE)–#custom—Healee, providing highly configurable digital health technology, announced today that it has raised $2M in a seed round led by Nina Capital, with the participation of Calm\/Storm Ventures, KAYA VC and existing investor Eleven … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47799","6":"format-standard","7":"category-industry"},"yoast_head":"\nHealee Lands $2M to Grow Customizable Telehealth Solution in the U.S. - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Healee Lands $2M to Grow Customizable Telehealth Solution in the U.S. - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"New funding round led by Nina Capital enables Healee to empower unique digital health models and accelerate telehealth adoption TAMPA, Fla.–(BUSINESS WIRE)–#custom—Healee, providing highly configurable digital health technology, announced today that it has raised $2M in a seed round led by Nina Capital, with the participation of Calm\/Storm Ventures, KAYA VC and existing investor Eleven ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-30T12:02:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220830005097\/en\/1555187\/21\/healee-logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Healee Lands $2M to Grow Customizable Telehealth Solution in the U.S.\",\"datePublished\":\"2022-08-30T12:02:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\\\/\"},\"wordCount\":512,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220830005097\\\/en\\\/1555187\\\/21\\\/healee-logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\\\/\",\"name\":\"Healee Lands $2M to Grow Customizable Telehealth Solution in the U.S. - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220830005097\\\/en\\\/1555187\\\/21\\\/healee-logo.jpg\",\"datePublished\":\"2022-08-30T12:02:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220830005097\\\/en\\\/1555187\\\/21\\\/healee-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220830005097\\\/en\\\/1555187\\\/21\\\/healee-logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Healee Lands $2M to Grow Customizable Telehealth Solution in the U.S.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Healee Lands $2M to Grow Customizable Telehealth Solution in the U.S. - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/","og_locale":"en_US","og_type":"article","og_title":"Healee Lands $2M to Grow Customizable Telehealth Solution in the U.S. - Pharma Trend","og_description":"New funding round led by Nina Capital enables Healee to empower unique digital health models and accelerate telehealth adoption TAMPA, Fla.–(BUSINESS WIRE)–#custom—Healee, providing highly configurable digital health technology, announced today that it has raised $2M in a seed round led by Nina Capital, with the participation of Calm\/Storm Ventures, KAYA VC and existing investor Eleven ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-30T12:02:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220830005097\/en\/1555187\/21\/healee-logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Healee Lands $2M to Grow Customizable Telehealth Solution in the U.S.","datePublished":"2022-08-30T12:02:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/"},"wordCount":512,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220830005097\/en\/1555187\/21\/healee-logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/","url":"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/","name":"Healee Lands $2M to Grow Customizable Telehealth Solution in the U.S. - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220830005097\/en\/1555187\/21\/healee-logo.jpg","datePublished":"2022-08-30T12:02:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220830005097\/en\/1555187\/21\/healee-logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220830005097\/en\/1555187\/21\/healee-logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Healee Lands $2M to Grow Customizable Telehealth Solution in the U.S."}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47799"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47799\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}